For the first time, the Food and Drug Administration (FDA) approved a drug derived from marijuana for the treatment of epilepsy.
The compound, known as cannabidiol, or CBD, has long been thought effective in the treatment of seizures. However, patients who wanted the plant extract—and the families that support their treatment—have been caught in a grey area between Federal and local laws.
In states like Colorado and California, cultivation and sale of medical marijuana is legal. Federally, however, marijuana is still considered a Schedule I drug.
Many applaud the FDA’s recent approval as a victory that will slowly unwind marijuana’s controversial status as a “drug” in the eyes of the Federal law.